Recombinant human bone morphogenetic protein-2: adverse events reported to the Manufacturer and User Facility Device Experience database.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  The spine journal

• Publication date

  2012-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.spinee.2012.09.052PMID 23098616
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Retrograde ejaculation after anterior lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a 10-year cohort controlled study.

  2012cited by this paper
• Radiographic and CT evaluation of recombinant human bone morphogenetic protein-2-assisted spinal interbody fusion.

  2011influential reference
• A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned.

  2011cited by this paper
• Retrograde ejaculation after anterior lumbar interbody fusion using rhBMP-2: a cohort controlled study.

  2011cited by this paper
• Complications Related to Osteobiologics Use in Spine Surgery: A Systematic Review

  2010cited by this paper
• Off-Label Use of Bone Morphogenetic Proteins in the United States Using Administrative Data

  2010cited by this paper
• Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion.

  2010cited by this paper
• Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures.

  2009cited by this paper
• Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis.

  2009cited by this paper
• Complications associated with single-level transforaminal lumbar interbody fusion.

  2009cited by this paper
• A COMPREHENSIVE REVIEW OF THE SAFETY PROFILE OF BONE MORPHOGENETIC PROTEIN IN SPINE SURGERY

  2008cited by this paper
• Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2).

  2008cited by this paper
• Increased Swelling Complications Associated With Off-Label Usage of rhBMP-2 in the Anterior Cervical Spine

  2007cited by this paper
• Heterotopic Bone Formation With the Use of rhBMP2 in Posterior Minimal Access Interbody Fusion: A CT Analysis

  2007cited by this paper
• Increased Swelling Complications Associated With Off-Label Usage of rhBMP-2 in the Anterior Cervical Spine

  2006cited by this paper
• Graft Resorption With the Use of Bone Morphogenetic Protein: Lessons From Anterior Lumbar Interbody Fusion Using Femoral Ring Allografts and Recombinant Human Bone Morphogenetic Protein-2

  2006cited by this paper
• Adverse Effects Associated With High-Dose Recombinant Human Bone Morphogenetic Protein-2 Use in Anterior Cervical Spine Fusion

  2006cited by this paper
• Vertebral Bone Resorption After Transforaminal Lumbar Interbody Fusion With Bone Morphogenetic Protein (rhBMP-2)

  2006influential reference
• Retrograde ejaculation after anterior lumbar interbody fusion.

  2004cited by this paper
• A Prospective, Randomized, Controlled Cervical Fusion Study Using Recombinant Human Bone Morphogenetic Protein-2 With the CORNERSTONE-SR™ Allograft Ring and the ATLANTIS™ Anterior Cervical Plate

  2003cited by this paper
• Use of Recombinant Human Bone Morphogenetic Protein-2 to Achieve Posterolateral Lumbar Spine Fusion in Humans: A Prospective, Randomized Clinical Pilot Trial 2002 Volvo Award in Clinical Studies

  2002cited by this paper
• Anterior Lumbar Interbody Fusion Using rhBMP-2 With Tapered Interbody Cages

  2002cited by this paper
• 3:51 Recombinant human bone morphogenic protein–2 for posterolateral spine fusion

  2002cited by this paper
• Confounding by indication: an example of variation in the use of epidemiologic terminology.

  1999cited by this paper

• Bezeotermin Alfa (rhBMP-6) Administration in Lumbar Interbody Fusion Surgery Using a Posterior Approach: A Randomized, Double-Blinded, Placebo-Controlled Phase-2 Study.

  2025cites this paper
• Anterior lumbar interbody fusion with a novel osteoinductive allograft – mid-term clinical and radiographic outcomes

  2025cites this paper
• Advances in tissue engineering strategies for periodontal and endodontic regeneration: Current therapies and future trends for disease treatment and tissue repair in the oral cavity.

  2025cites this paper
• Assessing the Reproducibility of Research Based on the Food and Drug Administration Manufacturer and User Facility Device Experience Data

  2024cites this paper
• An Analysis of the Complication Reports of Expandable Lumbar Interbody Cages in the Food and Drug Administration Manufacturer and User Facility Device Experience Database.

  2024cites this paper
• Off-Label Bone Morphogenetic Protein 2 Use Results in Successful Posterolateral Lumbar Fusion in a Veteran Population

  2024cites this paper
• Increased BMP-Smad signaling does not affect net bone mass in long bones

  2023cites this paper
• LCN2 inhibits the BMP9-induced osteogenic differentiation through reducing Wnt/β-catenin signaling via interacting with LRP6 in mouse embryonic fibroblasts.

  2023cites this paper
• CTR9 drives osteochondral lineage differentiation of human mesenchymal stem cells via epigenetic regulation of BMP-2 signaling

  2022cites this paper
• PI3K-Akt signaling regulates BMP2-induced osteogenic differentiation of mesenchymal stem cells (MSCs): A transcriptomic landscape analysis.

  2022cites this paper
• Cytokines, Chemokines, Alpha-2-Macroglobulin, Growth Factors

  2022cites this paper
• Uso de proteínas morfogenéticas óseas en la reconstrucción de defectos maxilofaciales causados por carcinoma escamoso oral: ¿es seguro su uso?

  2022cites this paper
• Osteogenic Differentiation of Human Adipose-Derived Stem Cells Seeded on a Biomimetic Spongiosa-like Scaffold: Bone Morphogenetic Protein-2 Delivery by Overexpressing Fascia

  2022cites this paper
• Effectiveness and Feasibility of Injectable Escherichia coli‐Derived Recombinant Human Bone Morphogenetic Protein‐2 for Anterior Lumbar Interbody Fusion at the Lumbosacral Junction in Adult Spinal Deformity Surgery: A Clinical Pilot Study

  2022cites this paper
• Roles of osteoclasts in alveolar bone remodeling

  2022cites this paper
• Material-driven fibronectin and vitronectin assembly enhances BMP-2 presentation and osteogenesis

  2022cites this paper
• Recombinant human bone morphogenetic protein-2 in spine surgery: recommendations for use and alternative bone substitutes—a narrative review

  2022cites this paper
• Mechanobiology-informed regenerative medicine: Dose-controlled release of placental growth factor from a functionalized collagen-based scaffold promotes angiogenesis and accelerates bone defect healing.

  2021cites this paper
• Materials-driven fibronectin assembly on nanoscale topography enhances mesenchymal stem cell adhesion, protecting cells from bacterial virulence factors and preventing biofilm formation.

  2021cites this paper
• A Cross-sectional Analysis of 284 Complications for Lumbar Disc Replacements from Medical Device Reports Maintained by the United States Food and Drug Administration.

  2021cites this paper
• Impact of surgeon rhBMP-2 cost awareness on complication rates and health system costs for spinal arthrodesis.

  2021cites this paper
• Minimally invasive scoliosis surgery for adolescent idiopathic scoliosis using posterior mini-open technique.

  2021cites this paper
• Semaphorin 3A promotes the osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells in inflammatory environments by suppressing the Wnt/β-catenin signaling pathway

  2021cites this paper
• Core Ossification of Bone Morphogenetic Protein-2-Loaded Collagenated Bone Mineral in the Sinus

  2020cites this paper
• PEA polymer-coated nanotopography delivers solid-state BMP2, enhances mesenchymal stem cell adhesion, prevents bacterial biofilm formation and protects cells from quorum sensing virulence factors

  2020cites this paper
• Effectiveness and feasibility of injectable Escherichia coli- derived recombinant human bone morphogenetic protein-2 on anterior lumbar interbody fusion at lumbosacral junction for adult spinal deformity: A clinical pilot study

  2020cites this paper
• Bone tissue engineering

  2020cites this paper
• A cross-sectional analysis of 1347 complications for cervical disc replacements from medical device reports maintained by the United States Food and Drug Administration.

  2020cites this paper
• Non-viral delivery of the BMP2 gene for bone regeneration

  2020cites this paper
• Innovative Molecular and Cellular Therapeutics in Cleft Palate Tissue Engineering

  2020cites this paper
• Controversy of physiological vs. pharmacological effects of BMP signaling: Constitutive activation of BMP type IA receptor-dependent signaling in osteoblast lineage enhances bone formation and resorption, not affecting net bone mass.

  2020cites this paper
• Sticky bone-specific artificial extracellular matrix for stem cell-mediated rapid craniofacial bone therapy

  2020cites this paper
• The Incorporation of Marine Coral Microparticles into Collagen-Based Scaffolds Promotes Osteogenesis of Human Mesenchymal Stromal Cells via Calcium Ion Signalling

  2020cites this paper
• Value of single-level circumferential fusion: a 10-year prospective outcomes and cost-effectiveness analysis comparing posterior facet versus pedicle screw fixation

  2019cites this paper
• Surface functionalisation of poly L-lactic acid to control protein organisation and growth factor presentation in tissue engineering

  2019cites this paper
• Enhancement of MicroRNA-200c on Osteogenic Differentiation and Bone Regeneration by Targeting Sox2-Mediated Wnt Signaling and Klf4

  2019cites this paper
• Biomaterial-based endochondral bone regeneration: a shift from traditional tissue engineering paradigms to developmentally inspired strategies

  2019cites this paper
• Applications of Bone Morphogenetic Protein-2: Alternative Therapies in Craniofacial Reconstruction.

  2019cites this paper
• Off-Label Use in Orthopaedic Surgery.

  2019cites this paper
• Gene activated adipose tissue fragments as advanced autologous biomaterials for bone regeneration: osteogenic differentiation within the tissue and implications for clinical translation

  2019cites this paper
• Critical-size alveolar defect treatment via TGF-ß3 and BMP-2 releasing hybrid constructs

  2019cites this paper
• Simultaneous Boron Ion‐Channel/Growth Factor Receptor Activation for Enhanced Vascularization

  2018cites this paper
• Osteoconductive layer-by-layer films of Poly(4-hydroxy-L-proline ester) (PHPE) and Tannic acid

  2018cites this paper
• Analysis of 4063 complications of shoulder arthroplasty reported to the US Food and Drug Administration from 2012 to 2016.

  2018cites this paper
• Designing stem cell niches for differentiation and self-renewal

  2018cites this paper
• Osseointegrative effect of rhBMP-2 covalently bound on a titan-plasma-spray-surface after modification with chromosulfuric acid in a large animal bone gap-healing model with the Göttingen minipig

  2018cites this paper
• Engineered systems to study the synergistic signaling between integrin-mediated mechanotransduction and growth factors (Review).

  2018cites this paper
• Nanoscale Coatings for Ultralow Dose BMP‐2‐Driven Regeneration of Critical‐Sized Bone Defects

  2018cites this paper
• Spin-off use of adverse events data: why and how. The case of FDA’s MAUDE

  2018cites this paper
• Forces associated with launch into space do not impact bone fracture healing.

  2018cites this paper
• Collagen-based biomaterials for tissue regeneration and repair

  2018cites this paper
• Evaluation of a Novel Recombinant Human Bone Morphogenetic Protein-2 Bioimplant for Alveolar Ridge Augmentation in Dogs

  2018cites this paper
• Differentiation of nerve-derived adult pluripotent stem cells into osteoblastic and endothelial cells.

  2017cites this paper
• Comparison of a calcium phosphate bone substitute with recombinant human bone morphogenetic protein-2: a prospective study of fusion rates, clinical outcomes and complications with 24-month follow-up

  2017cites this paper
• Efficacy of Early Fusion With Local Bone Graft and Platelet-Rich Plasma in Lumbar Spinal Fusion Surgery Followed Over 10 Years

  2017cites this paper
• Quiescent pluripotent stem cells reside within murine peripheral nerves that can be stimulated to proliferate by recombinant human bone morphogenic protein 2 or by nerve trauma.

  2017cites this paper
• In vitro and long-term (2-year follow-up) in vivo osteogenic activities of human periosteum-derived osteoblasts seeded into growth factor-releasing polycaprolactone/pluronic F127 beads scaffolds.

  2017cites this paper
• Current approaches for modulation of the nanoscale interface in the regulation of cell behavior

  2017cites this paper
• Mechanotransduction and Growth Factor Signalling to Engineer Cellular Microenvironments

  2017cites this paper
• Bone Morphogenetic Proteins in Pediatric Spinal Arthrodesis: A Statewide Analysis of Trends and Outcome of Utilization

  2017cites this paper
• Biomaterials to Facilitate Delivery of RNA Agents in Bone Regeneration and Repair.

  2017cites this paper
• Development of URIST™ a Multiphasic rhBMP-2 Bone Graft Substitute

  2017cites this paper
• 4.11 Nanoscale Surface Cues and Cell Behavior

  2017cites this paper
• Material-driven fibronectin fibrillogenesis to engineer cell function.

  2017influential citation
• High‐dose recombinant human bone morphogenetic protein‐2 impacts histological and biomechanical properties of a cervical spine fusion segment: results from a sheep model

  2017cites this paper
• Use of salicylic acid polymers and bone morphogenetic protein-2 to promote bone regeneration in rabbit parietal bone defects

  2016cites this paper
• The potential impact of bone tissue engineering in the clinic.

  2016cites this paper
• Sustained release of bioactive protein from a lyophilized tissue‐engineered construct promotes the osteogenic potential of mesenchymal stem cells

  2016cites this paper
• Effectiveness and safety of recombinant human bone morphogenetic protein-2 for adults with lumbar spine pseudarthrosis following spinal fusion surgery

  2016cites this paper
• Material-driven fibronectin assembly for high-efficiency presentation of growth factors

  2016cites this paper
• Three-Dimensional Upper Lip and Nostril Sill Changes After Cleft Alveolus Reconstruction Using Autologous Bone Grafting Versus Recombinant Human Bone Morphogenetic Protein-2

  2016cites this paper
• Extracellular matrix-inspired growth factor delivery systems for bone regeneration.

  2015cites this paper
• The effect of the bioactive sphingolipids S1P and C1P on multipotent stromal cells – new opportunities in regenerative medicine

  2015cites this paper
• Improving the osteogenic efficacy of BMP2 with mechano growth factor by regulating the signaling events in BMP pathway

  2015influential citation
• Gene Therapy for Bone Engineering

  2015cites this paper
• Bone regeneration with biomaterials and active molecules delivery.

  2015cites this paper
• Three-Dimensional Changes of Maxilla after Secondary Alveolar Cleft Repair: Differences Between rhBMP-2 and Autologous Iliac Crest Bone Grafting

  2015cites this paper
• Stability and Load Sharing Characteristics of a Posterior Dynamic Stabilization Device

  2015cites this paper
• Nanotopography as a tool for the investigation of molecular mechanisms of osteogenesis of MSCs

  2015cites this paper
• Aptamer-functionalized Hydrogels for the Programmable Release of Growth Factors

  2014cites this paper
• Drugs that Act on the Immune System: Cytokines and Monoclonal Antibodies

  2014cites this paper
• Bone morphogenetic protein use in the cervical spine: questions about safety and effectiveness.

  2014cites this paper
• Basic science and spine literature document bone morphogenetic protein increases cancer risk

  2014cites this paper
• Postmarketing safety of biologics and biological devices.

  2014cites this paper
• Side Effects of Cytokines Approved for Therapy

  2014cites this paper
• Neoplasia following use of BMPs: is there an increased risk?

  2014influential citation
• Anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2: a prospective study of complications.

  2014cites this paper
• The effects of 3D bioactive glass scaffolds and BMP-2 on bone formation in rat femoral critical size defects and adjacent bones

  2014cites this paper
• Commentary: Bone morphogenetic protein's contribution to pulmonary artery hypertension: Should this raise concern for patients undergoing spinal fusions with bone morphogenetic protein?

  2014cites this paper
• Bone healing with oxytocin-loaded microporous β-TCP bone substitute in ectopic bone formation model and critical-sized osseous defect of rat.

  2014cites this paper
• BMP-2 Promotes Oral Squamous Carcinoma Cell Invasion by Inducing CCL5 Release

  2014cites this paper
• COMP-Angiopoietin1 Potentiates the Effects of Bone Morphogenic Protein-2 on Ischemic Necrosis of the Femoral Head in Rats

  2014cites this paper
• Complications, revision fusions, readmissions, and utilization over a 1-year period after bone morphogenetic protein use during primary cervical spine fusions.

  2014cites this paper
• Delivery of S1P receptor-targeted drugs via biodegradable polymer scaffolds enhances bone regeneration in a critical size cranial defect.

  2014cites this paper
• Growth Factors Engineered for Super-Affinity to the Extracellular Matrix Enhance Tissue Healing

  2014cites this paper
• Osteogenetic properties of electrospun nanofibrous PCL scaffolds equipped with chitosan-based nanoreservoirs of growth factors.

  2014cites this paper
• Fixation with C-2 laminar screws in occipitocervical or C1-2 constructs in children 5 years of age or younger: a series of 18 patients.

  2014cites this paper
• Bone Tissue Engineering: Clinical Challenges and Emergent Advances in Orthopedic and Craniofacial Surgery

  2014cites this paper
• Transforaminal lumbar interbody fusion rates in patients using a novel titanium implant and demineralized cancellous allograft bone sponge

  2013cites this paper
• High-concentration of BMP2 reduces cell proliferation and increases apoptosis via DKK1 and SOST in human primary periosteal cells.

  2013cites this paper